Methods and systems for solution based sequence enrichment

Patent metadata

Field	Value
Publication number	US-9790543-B2
Application number	US-201113239585-A
Country	US
Kind code	B2
Filing date	Sep 22, 2011
Priority date	Oct 23, 2007
Publication date	Oct 17, 2017
Grant date	Oct 17, 2017

Abstract

The present invention provides methods and systems for the capture and enrichment of target nucleic acids and analysis of the enriched target nucleic acids. In particular, the present invention provides for the enrichment of targeted sequences in a solution based format.

First claim

The invention claimed is:

1. A method for reducing the genetic complexity of a plurality of nucleic acid molecules, the method comprising, in order, the steps of:
a) providing a plurality of support-immobilized oligonucleotide probes defining a complete sequence of at least one genetic locus having a size of at least 100 kb;
b) amplifying said support-immobilized oligonucleotide probes in solution in the presence of a nucleotide containing a binding moiety to generate a pool of amplification products derived from the support-immobilized oligonucleotide probes, wherein the pool of amplification products contain the binding moiety, and wherein the pool of amplification products are maintained in solution;
c) contacting under aqueous conditions the pool of amplification products generated in step b) to a sample that comprises a plurality of fragmented nucleic acid molecules, a subset of the plurality of fragmented nucleic acid molecules being target nucleic acid molecules having target nucleic acid sequences;
d) capturing the target nucleic acid molecules in hybridization complexes with the pool of amplification products, by providing a binding partner for the binding moiety;
e) separating the hybridization complexes from unbound and non-specifically bound nucleic acids; and
f) eluting the captured target nucleic acid molecules from the hybridization complexes in an eluate pool having reduced genetic complexity relative to the sample, wherein the eluate pool is enriched for the target nucleic acid molecules.

2. The method of claim 1 , wherein said support in step a) is a microarray slide.

3. The method of claim 1 , wherein the at least one genetic locus has a size of at least 1 Mb.

4. The method of claim 1 , wherein the pool of amplification products comprises overlapping sequences defining the complete sequence of the at least one genetic locus.

5. The method of claim 1 , wherein said plurality of fragmented nucleic acid molecules comprises genomic nucleic acid molecules.

6. The method of claim 5 , wherein said fragmented nucleic acid molecules further comprise a terminal adaptor molecule on at least one terminus.

7. The method of claim 1 , wherein said oligonucleotide probes further comprise a primer binding sequence on at least one end.

8. The method of claim 7 , wherein said primer binding sequences when present at both ends of the oligonucleotide probes are one of identical and different.

9. The method of claim 1 , wherein said amplifying comprises polymerase chain reaction.

10. The method of claim 1 , wherein said binding moiety is biotin and said binding partner is streptavidin.

11. The method of claim 10 , wherein the streptavidin is provided on a streptavidin-coated substrate.

12. The method of claim 11 , wherein said streptavidin-coated substrate is a streptavidin-coated paramagnetic particle.

13. The method of claim 1 , further comprising washing said separated hybridization complexes prior to elution.

14. The method of claim 1 , further comprising sequencing the eluted target nucleic acid sequences.

15. A method for reducing the genetic complexity of a plurality of nucleic acid molecules, the method comprising, in order, the steps of:
a) amplifying into solution, in the presence of a nucleotide covalently linked to a binding moiety, a plurality of support-immobilized oligonucleotide probes hybridizable to target nucleic acid sequences, to produce, in solution, amplification products comprising the binding moiety;
b) purifying the amplification products away from the support-immobilized oligonucleotide probes;
c) contacting the amplification products, under aqueous hybridizing conditions, to a sample that comprises the plurality of fragmented nucleic acid molecules, a subset of the plurality being target nucleic acid molecules having the target nucleic acid sequences, to capture the target nucleic acid molecules in hybridization complexes with the amplification products;
d) providing a binding partner for the binding moiety and separating the hybridization complexes from unbound and non-specifically bound nucleic acids; and
e) eluting the captured target nucleic acid molecules from the hybridization complexes in an eluate pool comprising the plurality of nucleic acid molecules having reduced genetic complexity relative to the sample, wherein the eluate pool is enriched for target nucleic acid molecules as compared to a sample not having reduced genetic complexity.

16. The method of claim 15 , wherein said support is a microarray slide.

17. The method of claim 15 , wherein the eluate pool comprises a plurality of genomic nucleic acid molecules.

18. The method of claim 15 , wherein said fragmented nucleic acid molecules further comprise a terminal adaptor molecule on at least one terminus.

19. The method of claim 15 , wherein said oligonucleotide probes further comprise a primer binding sequence on at least one end.

20. The method of claim 19 , wherein said primer binding sequences when present at both ends of the probes are one of identical and different.

21. The method of claim 15 , wherein said amplifying comprises polymerase chain reaction.

22. The method of claim 15 , wherein said binding moiety is biotin and said binding partner is streptavidin.

23. The method of claim 22 , wherein the streptavidin is provided on a streptavidin-coated substrate.

24. The method of claim 23 , wherein said streptavidin-coated substrate is a streptavidin-coated paramagnetic particle.

25. The method of claim 15 , further comprising washing said separated hybridization complexes prior to elution.

26. The method of claim 15 , further comprising sequencing the eluted target nucleic acid sequences.

27. The method of claim 1 , wherein the eluate pool is enriched for target nucleic acid molecules by at least 400-fold to at least 2600-fold.

28. The method of claim 1 , wherein the step f) of eluting comprises heat denaturation.

29. The method of claim 1 , further comprising purifying the pool of amplification products away from the support-immobilized oligonucleotide probes prior to step c).

Assignees

• Rodesch Matthew
• Albert Thomas
• Roche Sequencing Solutions Inc

Inventors

• Rodesch Matthew
• Albert Thomas

Classifications

• C12N15/1006

  by means of a solid support carrier, e.g. particles, polymers · CPC title

• C12Q2537/159

  Reduction of complexity, e.g. amplification of subsets, removing duplicated genomic regions · CPC title

• C12Q1/6844

  Nucleic acid amplification reactions · CPC title

• C12Q1/6813 Primary

  Hybridisation assays · CPC title

• C12Q1/6806

  Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title